Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
B. Cai (Florham Park, NJ, United States of America), R. Echols (Easton, CT, United States of America), F. Corvino (Hoboken, NJ, United States of America), D. Rudin (Florham Park, NJ, United States of America), G. Morgan (Florham Park, NJ, United States of America), Y. Matsunaga (Florham Park, NJ, United States of America), M. Ariyasu (Osaka, Japan), T. Sawada (Osaka, Japan), T. Nagata (Osaka, Japan). Carbapenem-resistance pathogens in HAP/VAP patients in US hospitals between 2010 and 2015. 2636

Member's Comments

No comment yet.

Related content which might interest you: Treatment outcomes of MDR-TB patients notified in Romania during 2005-2007 Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011 Mortality and associated factors among drug-resistant tuberculosis patients in Portugal, 2000-2016 Source: Virtual Congress 2020 – Tuberculosis: part 2 Year: 2020 Klebsiella pneumoniae respiratory isolates in an urban-based general hospital - trends and characteristics between 1998 and 2003 Source: Eur Respir J 2005; 26: Suppl. 49, 258s Year: 2005 Resistance to nosocomial pneumonia pathogens in 2005-2006 and in 2007 in Yaroslavl (Russia) Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010 The dynamics of antibiotic resistance of nasopharyngeal pneumococcus isolates in children in Moscow for 2010-2018 Source: Virtual Congress 2020 – Clinical challenges in pneumonia Year: 2020 The management of MDR TB cases registered in the 4th sector of Bucharest during 2004-2006 Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis Year: 2010 Management of MDR and rifampicin-resistant TB cases in Italy, 1995-1999 Source: Eur Respir J 2001; 18: Suppl. 33, 513s Year: 2001 Adherence of drug-resistant tuberculosis patients to treatment in Tashkent, 2019-2020 Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis Year: 2021 Treatment outcomes and deaths among multidrug-resistant tuberculosis (MDR-TB) patients in Gomel region, Belarus – 2009-2010 Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights Year: 2013 The prognosis of patients colonized and infected with pulmonary nontuberculous mycobacteria in Denmark, 1997-2007: a nationwide population-based study Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections Year: 2009 Incidence of hospitalized all-cause pneumonia, and serotype distribution of hospitalized streptococcus pneumoniae pneumonia in Norway 2008-2009 Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013 Treatment outcome of XDR-TB patients in Iran during 2003-2006 Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis Year: 2008 Mortality associated factors of patients admitted due to flu during 2015-2016 and 2016-2017 Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia Year: 2018 The burden of respiratory infections caused by resistant bacteria and need for antibiotics stewardship program in Balochistan, Pakistan Source: International Congress 2018 – Preclinical and clinical studies of critical illness Year: 2018 Management and outcome of opportunistic mycobacterial infections in non-HIV patients in Leeds: 1995-2000 Source: Eur Respir J 2001; 18: Suppl. 33, 473s Year: 2001 The impact of pandemics and quality interventions on trends in hospitalized penumonia 2001-2012 Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system Year: 2013 Treatment outcomes of MDR-TB cases registered in Bucharest sector 4 during 2004-2008 Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012 First national survey results of mycobacterium tuberculosis drug resistance in Kosovo, 2007-2008 Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2011 Rifampicin-resistant tuberculosis in Singapore, 2005 to 2018 Source: International Congress 2019 – Tuberculosis: treatment and management Year: 2019 Surveillance of multi-drug resistance and phenotypes of Acinetobacter baumannii isolates producing extended-spectrum-beta-lactamases (ESBLs) from hospital acquired pneumonia patients in west China Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections Year: 2009